← Back to all earnings calls

Avalo Therapeutics, Inc. Q2 FY2021 Earnings Call

Avalo Therapeutics, Inc. (AVTX)

Earnings Call FY2021 Q2 Call date: 2021-08-02 Concluded

Share

Quarter scorecard

Revenue

$3.35M

+150.7% YoY

Net income

$

Revenue · products & services

Product $2.73M

+104%

License $625,000

Documents & deck